
Superpower peptides available for pre-order. Get first access.

Peptide science
Do topical peptides penetrate skin?
Do peptides penetrate skin? In lab studies most stay in the outer layer. See what penetration data show for GHK-Cu, Argireline, and palmitoyl peptides.
Quick answer
Most topical peptides do not penetrate far. In lab studies on excised skin, unmodified KTTKS (about 564 Da) was not detected in any layer. Palmitoylated KTTKS reached 4.2 µg/cm² in the stratum corneum and 0.3 µg/cm² in the dermis. Argireline left about 0.22% of the applied dose in human cadaver stratum corneum. Fatty-acid attachment and delivery systems, not size alone, change the result.
- Published
- November 11, 2026
- Last updated
- November 11, 2026
Some peptides penetrate skin, but most stay near the surface
Some topical peptides penetrate skin, but in lab studies on excised skin, most applied peptide stays on the surface or in the skin's outer layer. Most anti-wrinkle peptides are poor candidates1 for crossing skin unaided. An attached fatty acid or a delivery method such as microneedles can raise how much gets in.
The common claim that skincare peptides are small enough to penetrate overstates the research, since many may not reach their targets in skin1. Low skin absorption starts with how the outer layer is built.
Why skin keeps most peptides out
Skin keeps most peptides out because its outer layer is a fat-based barrier, and most peptides are large, water-loving molecules with charged groups1. Enzymes in skin can also break peptides apart.
That outer layer, the stratum corneum, keeps unwanted materials out and water in2. Ceramides, cholesterol, and free fatty acids between its cells form the only continuous path through the layer3.
By a widely cited rule of thumb, compounds need to weigh under 500 daltons (Da)4 to cross. Common skin allergens and skin-patch drugs nearly all fall below that size.
GHK-Cu, a copper-bound tripeptide, weighs about 403 Da5, under that limit. Yet in a lab study, almost no GHK-Cu or copper crossed6 intact human skin over nine hours.
Reaching the skin and staying stable7 are now core challenges for peptide ingredients. One long-used fix is an attached fatty acid.
How palmitoylation changes peptide penetration
Palmitoylation, attaching a fatty-acid chain called a palmitoyl group, helped palmitoyl pentapeptide-4 (pal-KTTKS) reach every layer of hairless mouse skin in a lab study. Without the chain, the same peptide was not detected8 in any layer.
In that skin, pal-KTTKS reached 4.2 µg/cm² (micrograms per square centimeter) in the stratum corneum, 2.8 µg/cm² in the epidermis, and 0.3 µg/cm² in the dermis8. Weight did not explain the gap, since pal-KTTKS weighs about 802 Da9 and the unmodified peptide roughly 564 Da10.
Ingredient makers reported that long fatty-acid chains improve skin penetration11 and activity while lowering cost.
Palmitoyl hexapeptide-12 also moved through the stratum corneum and epidermis12 of one human donor's skin in a lab study. GHK-Cu and Argireline, sold without a fatty-acid chain, have their own penetration data.
What penetration studies show for GHK-Cu and Argireline
A lab study on excised skin found very little Argireline below the outer layer13, while one GHK-Cu study tracked only its copper.
In thin-sliced (dermatomed) human skin, copper from GHK-Cu crossed14 over 48 hours. Tracking copper alone cannot show whether the tripeptide stayed intact.
Argireline, the trade name for acetyl hexapeptide-8 (also listed as acetyl hexapeptide-3), weighs about 887 Da15. Argireline was designed to damp the nerve signals behind muscle contraction16, so its target lies deep below the outer layer. Whether Argireline can reach those neuromuscular junctions17 from a cream remains uncertain.
Lab measurements of where applied peptides end up vary by peptide, skin model, and method.
| Peptide | Size | Skin model | What was measured | Where it ended up |
| KTTKS, unmodified | About 564 Da10 | Hairless mouse skin, in vitro | Intact peptide in each skin layer8 | Not detected in any layer |
| Palmitoyl pentapeptide-4 (pal-KTTKS) | About 802 Da9 | Hairless mouse skin, in vitro | Intact peptide in each skin layer8 | 4.2 µg/cm² stratum corneum, 2.8 µg/cm² epidermis, 0.3 µg/cm² dermis; none passed through |
| Copper tripeptide (GHK-Cu) | About 403 Da5 | Dermatomed human skin, in vitro, 48 hours | Copper only, not the intact peptide14 | 136.2 µg/cm² copper passed through; 82 µg/cm² copper stayed in skin |
| GHK-Cu | About 403 Da5 | Intact human skin, in vitro, 9 hours | Peptide and copper measured separately6 | Almost none of either crossed intact skin |
| GHK-Cu in liposomes | Not applicable | No skin model; formulation tests only | How much GHK-Cu the liposomes held18; enzyme tests | Not measured in skin |
| Acetyl hexapeptide-8 (Argireline) | About 887 Da15 | Hairless guinea pig and human cadaver skin, in vitro, 24 hours | Intact peptide from a 10% emulsion13 | Mostly washed off; 0.54% (guinea pig) and 0.22% (human) in stratum corneum; about 0.01% in epidermis; none in dermis |
Penetration this limited is why formulators also test delivery systems.
How delivery systems change topical peptide penetration
Microneedles and nanocarriers can raise peptide permeability1 in lab studies. Liposome data for GHK-Cu and pal-KTTKS come mostly from formulation and cell tests.
Microneedles open tiny channels in the outer layer. In excised human skin, microneedle pretreatment gave three fluorescent-tagged peptides, including pal-KTTKS, 2- to 22-fold more signal19 than without them.
Inside liposomes, tiny fat-based spheres, pal-KTTKS raised collagen output in mouse cell cultures20 more than the free peptide did. How GHK-Cu liposomes move through skin has received little research attention21.
Researchers also test microemulsions, nanoparticles, and solid lipid nanoparticles22 as carriers. A product label reveals only part of how such a formula is built.
What penetration data mean for peptide product claims
A peptide on an ingredient list reveals little about its amount, or how much reaches living skin instead of washing off the surface13.
One controlled facial trial tested pal-KTTKS at just three parts per million23. US labeling rules let ingredients at 1% or less appear in any order24 after those above 1%. A low-dose peptide's list position is therefore a weak guide to its amount.
Cell-culture results show what a peptide can do at skin cells. Penetration studies show whether a formula delivers the peptide to those cells1. Together, the two show what a cosmetic peptide claim rests on.
Where can I learn about peptides?
A cosmetic peptide claim is easier to judge once you know whether a cell study or a skin study sits behind it. Superpower’s peptide library covers individual peptides with that distinction in view. A team of health journalists and licensed clinicians writes and fact-checks every guide.
Size, fat solubility, and charge all shape a molecule's path through skin, and each traces back to the science behind peptides.
This content is provided by Superpower Health for educational and informational purposes only. Superpower Health does not prescribe, sell, or facilitate access to over-the-counter cosmetic peptide products. Topical cosmetic peptides are regulated as cosmetic ingredients, not as drugs, and have no FDA-approved therapeutic indication. This page is not a substitute for medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.